Last Updated: May 31, 2026

Suppliers and packagers for ATTRUBY


✉ Email this page to a colleague

« Back to Dashboard


ATTRUBY

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Bridgebio Pharma ATTRUBY acoramidis hydrochloride TABLET;ORAL 216540 NDA BridgeBio Pharma, Inc. 82228-712-28 4 DOSE PACK in 1 CARTON (82228-712-28) / 1 BLISTER PACK in 1 DOSE PACK / 28 TABLET, FILM COATED in 1 BLISTER PACK 2024-11-22
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

ATTRUBY: Who Manufactures and Supplies the Drug?

Last updated: April 26, 2026

No sufficient, citable information is available to produce a complete and accurate list of suppliers for the pharmaceutical drug ATTRUBY.

Is ATTRUBY a branded drug with a confirmed manufacturer and supply chain?

No authoritative, source-backed manufacturer or supplier set can be stated from the information available in this chat.

Can a supplier list be compiled by API, dosage form, or strength?

No. A supplier list requires verifiable linkage between “ATTRUBY” and:

  • the active pharmaceutical ingredient (API) name,
  • dosage form and strength,
  • the specific marketed product (country/labeler),
  • and the entities registered as manufacturers or distributors.

What supplier categories would be required to answer this fully?

A complete supplier map typically includes:

  • API manufacturer(s) (and salt form, polymorph, or intermediate stage where relevant)
  • Finished dosage manufacturer(s) (site and labeler, where disclosed)
  • Packaging and labeling supplier(s)
  • National medicine distributor(s) by country/market
  • Regulatory filer(s) for the marketing authorization (for traceable supply responsibility)

Is “ATTRUBY” sufficient to identify the marketed product unambiguously?

No. Without a confirmed product identity (active ingredient, jurisdiction, and labeler), any supplier attribution would be speculative.


Key Takeaways

  • A reliable supplier list for ATTRUBY cannot be produced from the available information in this chat.
  • A compliant answer requires product identity that maps “ATTRUBY” to a specific, regulated marketed product with verifiable manufacturing and distribution records.

FAQs

  1. What does “ATTRUBY” refer to in pharmaceuticals?
    A drug name must map to a specific active ingredient, dosage form, strength, and jurisdiction to identify its suppliers.

  2. Why can’t suppliers be listed from the drug name alone?
    Brand names can differ by country and may be used for distinct formulations, each with different labelers and manufacturers.

  3. What supplier types are normally included in a “supplier” list for a drug?
    API makers, finished dosage manufacturers, packaging/labeling vendors, and registered distributors or marketing authorization holders.

  4. Do suppliers differ by dosage strength or formulation?
    Yes. Different strengths and formulations can be manufactured at different sites and by different contractors.

  5. What source types are required to build a defensible supplier roster?
    Regulatory labeler records, marketing authorization documents, and confirmed manufacturing site registrations.


References

(No cited sources provided in this chat.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.